Vinva Investment Management Ltd Boosts Stock Position in Intuitive Surgical, Inc. $ISRG

Vinva Investment Management Ltd boosted its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 105.2% in the third quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 19,363 shares of the medical equipment provider’s stock after purchasing an additional 9,925 shares during the quarter. Vinva Investment Management Ltd’s holdings in Intuitive Surgical were worth $8,505,000 at the end of the most recent reporting period.

Several other hedge funds have also modified their holdings of ISRG. SteelPeak Wealth LLC lifted its position in Intuitive Surgical by 28.7% during the third quarter. SteelPeak Wealth LLC now owns 41,993 shares of the medical equipment provider’s stock valued at $18,781,000 after acquiring an additional 9,364 shares during the last quarter. Atlantic Union Bankshares Corp grew its holdings in Intuitive Surgical by 19.3% in the third quarter. Atlantic Union Bankshares Corp now owns 22,759 shares of the medical equipment provider’s stock worth $10,179,000 after purchasing an additional 3,676 shares during the last quarter. World Investment Advisors grew its holdings in Intuitive Surgical by 238.3% in the third quarter. World Investment Advisors now owns 5,399 shares of the medical equipment provider’s stock worth $2,415,000 after purchasing an additional 3,803 shares during the last quarter. E. Ohman J or Asset Management AB increased its position in shares of Intuitive Surgical by 4.1% during the third quarter. E. Ohman J or Asset Management AB now owns 28,306 shares of the medical equipment provider’s stock worth $12,659,000 after purchasing an additional 1,123 shares in the last quarter. Finally, Valley Wealth Managers Inc. increased its position in shares of Intuitive Surgical by 52.7% during the third quarter. Valley Wealth Managers Inc. now owns 4,084 shares of the medical equipment provider’s stock worth $1,826,000 after purchasing an additional 1,409 shares in the last quarter. 83.64% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

ISRG has been the subject of a number of recent analyst reports. Argus lowered their price objective on Intuitive Surgical from $630.00 to $560.00 and set a “buy” rating for the company in a research report on Wednesday, February 4th. Truist Financial boosted their price target on Intuitive Surgical from $620.00 to $650.00 and gave the stock a “buy” rating in a research note on Thursday, December 18th. Weiss Ratings restated a “hold (c+)” rating on shares of Intuitive Surgical in a report on Monday, December 29th. Barclays set a $712.00 price objective on shares of Intuitive Surgical and gave the company an “overweight” rating in a research report on Monday, January 26th. Finally, Piper Sandler reiterated an “overweight” rating and issued a $620.00 target price (up from $610.00) on shares of Intuitive Surgical in a research note on Friday, January 23rd. Two investment analysts have rated the stock with a Strong Buy rating, fifteen have issued a Buy rating, seven have assigned a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $615.86.

Insider Buying and Selling at Intuitive Surgical

In other news, SVP Patricia L. Wadors sold 220 shares of the company’s stock in a transaction on Friday, February 27th. The shares were sold at an average price of $499.71, for a total value of $109,936.20. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, SVP Mark Brosius sold 648 shares of the stock in a transaction on Thursday, March 5th. The stock was sold at an average price of $495.20, for a total transaction of $320,889.60. Following the completion of the sale, the senior vice president owned 2,906 shares in the company, valued at $1,439,051.20. The trade was a 18.23% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last 90 days, insiders sold 37,261 shares of company stock worth $19,690,721. Corporate insiders own 0.70% of the company’s stock.

Intuitive Surgical Stock Down 1.3%

Shares of NASDAQ:ISRG opened at $490.16 on Monday. Intuitive Surgical, Inc. has a 52-week low of $425.00 and a 52-week high of $603.88. The stock has a market cap of $174.07 billion, a price-to-earnings ratio of 62.12, a PEG ratio of 3.78 and a beta of 1.66. The business has a 50-day moving average price of $521.64 and a 200-day moving average price of $512.51.

Intuitive Surgical (NASDAQ:ISRG) last issued its earnings results on Thursday, January 22nd. The medical equipment provider reported $2.53 EPS for the quarter, beating analysts’ consensus estimates of $2.27 by $0.26. Intuitive Surgical had a return on equity of 15.06% and a net margin of 28.38%.The firm had revenue of $2.87 billion for the quarter, compared to analyst estimates of $2.72 billion. During the same quarter in the prior year, the firm earned $2.21 earnings per share. Intuitive Surgical’s revenue for the quarter was up 18.8% on a year-over-year basis. As a group, equities analysts anticipate that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

About Intuitive Surgical

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.